Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD34+Stem Cell Selection for Patients Receiving Partially Matched Family or Matched Unrelated Adult Donor Allogeneic Stem Cell Transplantations for Malignant and Non-Malignant Disease

NCT01049854 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.

NCT NCT01049854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01049854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD34+Stem Cell Selection for Patients Receiving Partially Matched Family or Matched Unrelated Adult Donor Allogeneic Stem Cell Transplantations for Malignant and Non-Malignant Disease
Lead sponsor
New York Medical College
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
August 31, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beta thalassemia, bone marrow failure, histiocytosis, immunodeficiencies, inborn errors of metabolism, leukemia, lymphoma, sickle cell disease